James Thrasher

机构：University of Arkansas Medical Center, Arkansas Cardiology, University of Arkansas for Medical Sciences

发表论文 36 篇 · 总被引 5535 次 · h-index 20

代表论文

Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial (2019 · The Lancet · 被引 3132)
Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial (2019 · The Lancet · 被引 641)
Semaglutide once weekly as add-on to SGLT-2 inhibitor therapy in type 2 diabetes (SUSTAIN 9): a randomised, placebo-controlled trial (2019 · The Lancet Diabetes & Endocrinology · 被引 376)
Efficacy and safety of dapagliflozin in patients with inadequately controlled type 1 diabetes (DEPICT-1): 24 week results from a multicentre, double-blind, phase 3, randomised controlled trial (2017 · The Lancet Diabetes & Endocrinology · 被引 295)
Efficacy and Safety of Dapagliflozin in Patients With Inadequately Controlled Type 1 Diabetes: The DEPICT-1 52-Week Study (2018 · Diabetes Care · 被引 241)
Safety and Glycemic Outcomes During the MiniMed™ Advanced Hybrid Closed-Loop System Pivotal Trial in Adolescents and Adults with Type 1 Diabetes (2021 · Diabetes Technology & Therapeutics · 被引 221)